RE: IMO15 May 2019 09:26
Totally agree. I sold out with a profit 1.4-2p as it wasn’t well researched but after looking into it further and the product that they have with the enormous market they can tap into i sold a few other to get in here. The CEO Gerry fills me with confidence who also has shares in here. CEO’s usually couldn’t give a rats arse but this guy does and together with the exceptional product Labskin and Gerry’s ability to turn micro caps to giants I am in big for. Good luck to us all.
Gerry’s Profile pinched from the net: He has pedigree that’s for sure!
Founder and CEO of Alltracel Pharma, a Start-up that was eventually sold for $55m in 2008 after first IPO in 2001.
Management buy-in and CEO of a second AIM-listed company, Integumen PLC in 2018.
He is CEO of Cellulac since 2012 in management buy-in. Cellulac was €300,000 in debt, had no cash, no assets, and no revenue. Since then, completed a number of multi-million Euro acquisitions and continues to grow. Value of last acquisition in 2015 was €23m.
Change management expertise in transforming early-stage science, and engineering companies, that are normally pre-revenue, into large multi-national commercial companies. Author of Real Business Secrets - Bootstrapping a Multinational Business Empire. How to transform loss-making, pre-revenue, early-stage, start-up science, engineering and consumer healthcare companies using a variety of financial engineering mechanisms and multi-continent strategic collaborations to reach the commercialisation stage.
Using capital markets, without venture capital, in failed or failing companies to complete 14 corporate transactions and a total of 5 London Stock Market listings in the last 22 years.